Consistent with these roles, GSEA revealed enrichment of IL-17, JAK-STAT, NF-κB, TGF-β, and TNF pathways in mono1, mono2, and mono5 (Figure 5D), suggesting a regulatory network that sustains pulmonary inflammation and fibrosis—key pathological features of ILD. Here, IL17A is linked to interstitial lung disease.